Winton Group’s Vicarious Surgical RBOT Stock Holding History

Winton Group’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-517	Closed	-$9.16K	–	843
2023 Q3	$9.16K	Buy	+517	New	+$18.8K	﹤0.01%	756

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

MAMHA

MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Winton Group's RBOT Position: Q4 2023 in Review

Winton Group sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 517 shares — an estimated $9.16K sold.

Winton Group first reported a position in RBOT in Q3 2023 and held it in 1 quarter. The position peaked at $9.16K in Q3 2023. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

Winton Group reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
Winton Group sold 517 Vicarious Surgical shares in Q4 2023, an estimated $9.16K.
Winton Group first reported a position in Vicarious Surgical in Q3 2023 and held it in 1 quarter.
Winton Group's Vicarious Surgical position peaked at $9.16K in Q3 2023.
72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Winton Group's 13F filing for Q4 2023, filed 12 Feb 2024.